Archive · 3 Aug 2025
Bengaluru Startup Uses Quantum Tech for Early Cancer Detection
Imagine tiny sensors that can spot damage inside your body before you even feel sick!
A team in Bengaluru is working on this using special 'quantum' technology.
They want to find early signs of cancer or damage from treatments like radiation.
This new tech looks for tiny signals that show stress in cells, potentially finding problems much faster than current tests.
The goal is to help doctors catch issues earlier and give better care, even helping with crowded hospitals by identifying those needing critical care quickly.
This involves teaming up with hospitals and researchers to develop a more efficient method for diagnosing cellular stress.
A Bengaluru-based startup is developing quantum technology to detect cellular damage for early cancer care.
The tech uses a quantum biosensor to identify magnetic fingerprints of oxidative stress, detecting tissue injury before symptoms.
The technology is being developed by Quantum Biosciences Private Limited, which was at the Quantum India Bengaluru Summit.
The technology aims to detect damage from radiation therapy, which can have side effects.
The company is partnering with hospitals to gather data and validate the technology.
- Who
- Quantum Biosciences Private Limited, led by Ravi Puvvala and partnering with QT Sense.
- What
- A Bengaluru-based startup is developing quantum technology to detect cellular damage for early cancer care.
- When
- The research and development have been ongoing for at least two years, with the company planning to spend the next two years working with hospitals for testing.
- Where
- The startup is based in Bengaluru, India.
- Why
- To detect cellular damage earlier, improve cancer treatment outcomes, and reduce strain on healthcare systems.
- Startup Name
- Quantum Biosciences Private Limited
- Technology Type
- Quantum Biosensor
- Focus
- Early detection of cellular damage in cancer care
- Summit
- Quantum India Bengaluru Summit
- Partners
- QT Sense (Netherlands)
- Key Goal
- Reduce primary healthcare overload